KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Preferred Stock Liabilities: 2018

  • Twist Bioscience's Preferred Stock Liabilities was N/A to $290.5 million in Q3 2018 from the same period last year, while for Sep 2018 it was $290.5 million, marking a year-over-year change of. This contributed to the annual value of $290.5 million for FY2018, which is 127.18% up from last year.
  • As of Q3 2018, Twist Bioscience's Preferred Stock Liabilities stood at $290.5 million.
  • Twist Bioscience's 5-year Preferred Stock Liabilities high stood at $290.5 million for Q3 2018, and its period low was $290.5 million during Q3 2018.
  • In the last 1 years, Twist Bioscience's Preferred Stock Liabilities had a median value of $290.5 million in 2018 and averaged $290.5 million.